NEW YORK–(BUSINESS WIRE)– iCareDx, Inc., a biotechnology company focused on blood-based early
detection of cancer, today announced that it has changed its name to
Acuamark Diagnostics, Inc. In conjunction with its corporate name
change, the Company’s website will be available at www.acuamarkdx.com.
Globally, over 22,000 people die of cancer each day. When cancer is
detected at the early stages, survival rates are generally still high.
Finding cancer early with an accurate, convenient and affordable
technology, and attacking it early, can vastly reduce cancer deaths, and
substantially lower cancer-related healthcare expenditures.
Dr. Bernard Peperstraete, CEO of Acuamark Diagnostics, Inc. (formerly
iCareDx, Inc.) stated, « Our team is excited to re-brand the Company
as Acuamark Diagnostics. The name “Acuamark” incorporates several
elements that play to the essence of our corporate mission, and well
embodies the progress we have made towards developing an accurate
diagnostic screening technology to detect low-abundance tumor markers
from liquids at the earliest stages of cancer.”
Dr. Francis Barany, PhD, Professor of Microbiology and Immunology at the
Weill Cornell Medicine, and lead inventor of Acuamark Diagnostics’
molecular detection technologies, adds: “In addition, the name
Acuamark Diagnostics is a reflection that each cancer leaves a unique
watermark in our bodies, and as with a watermark, it is barely visible,
requiring one to see it in a different light.”
About Acuamark Diagnostics Inc.
Acuamark Diagnostics is a biotechnology company focused on developing
screening tests technologies for blood-based early detection of cancer.
Acuamark Diagnostics’ technology allows for highly accurate screening of
blood to detect cancer markers at the early cancer stages, before the
cancer becomes untreatable. Backed by a highly experienced team, it is
Acuamark Diagnostics’ mission to contribute to the global battle against
cancer by detecting and attacking cancer through high-precision, early
detection.
For more information, please visit www.acuamarkdx.com,
or contact us at info@acuamarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160921006580/en/
Contacts
Acuamark Diagnostics, Inc.
Bernard Peperstraete, MD
Chief
Executive Officer
info@acuamarkdx.com
Source: iCareDx, Inc
Cet article Early-Cancer Detection Company iCareDx Announces Corporate Name Change
To Acuamark Diagnostics est apparu en premier sur EEI-BIOTECHFINANCES.